[HTML][HTML] Artificial intelligence for COVID-19 drug discovery and vaccine development
SARS-COV-2 has roused the scientific community with a call to action to combat the growing
pandemic. At the time of this writing, there are as yet no novel antiviral agents or approved …
pandemic. At the time of this writing, there are as yet no novel antiviral agents or approved …
Epitope prediction by novel immunoinformatics approach: a state-of-the-art review
Immunoinformatics is a science that helps to create significant immunological information
using bioinformatics softwares and applications. One of the most important applications of …
using bioinformatics softwares and applications. One of the most important applications of …
Drug repurposing for coronavirus (COVID-19): in silico screening of known drugs against coronavirus 3CL hydrolase and protease enzymes
AD Elmezayen, A Al-Obaidi, AT Şahin… - Journal of Biomolecular …, 2021 - Taylor & Francis
Abstract In December 2019, COVID-19 epidemic was described in Wuhan, China, and the
infection has spread widely affecting hundreds of thousands. Herein, an effort was made to …
infection has spread widely affecting hundreds of thousands. Herein, an effort was made to …
An in silico deep learning approach to multi-epitope vaccine design: a SARS-CoV-2 case study
The rampant spread of COVID-19, an infectious disease caused by SARS-CoV-2, all over
the world has led to over millions of deaths, and devastated the social, financial and political …
the world has led to over millions of deaths, and devastated the social, financial and political …
Exploring the out of sight antigens of SARS-CoV-2 to design a candidate multi-epitope vaccine by utilizing immunoinformatics approaches
SARS-CoV-2 causes a severe respiratory disease called COVID-19. Currently, global health
is facing its devastating outbreak. However, there is no vaccine available against this virus …
is facing its devastating outbreak. However, there is no vaccine available against this virus …
[HTML][HTML] Design of a novel multiple epitope-based vaccine: An immunoinformatics approach to combat SARS-CoV-2 strains
Abstract Background Since the SARS-CoV-2 outbreak in December 2019 in Wuhan, China,
the virus has infected more than 153 million individuals across the world due to its human-to …
the virus has infected more than 153 million individuals across the world due to its human-to …
An overview of in silico vaccine design against different pathogens and cancer
K Kardani, A Bolhassani, A Namvar - Expert Review of Vaccines, 2020 - Taylor & Francis
Introduction Due to overcome the hardness of the vaccine design, computational
vaccinology is emerging widely. Prediction of T cell and B cell epitopes, antigen processing …
vaccinology is emerging widely. Prediction of T cell and B cell epitopes, antigen processing …
Analysis of the COVID-19 vaccine development process: an exploratory study of accelerating factors and innovative environments
HGT Defendi, L da Silva Madeira… - Journal of Pharmaceutical …, 2021 - Springer
Purpose The pace of the COVID-19 vaccine development process is unprecedented and is
challenging the traditional paradigm of vaccinology science. The main pressure comes from …
challenging the traditional paradigm of vaccinology science. The main pressure comes from …
Immunoinformatic design of a COVID-19 subunit vaccine using entire structural immunogenic epitopes of SARS-CoV-2
Abstract Coronavirus disease 2019 (COVID-19) is an acute pneumonic disease, with no
prophylactic or specific therapeutical solution. Effective and rapid countermeasure against …
prophylactic or specific therapeutical solution. Effective and rapid countermeasure against …
Nanotheranostics against COVID-19: From multivalent to immune-targeted materials
P Hassanzadeh - Journal of controlled release, 2020 - Elsevier
Destructive impacts of COVID-19 pandemic worldwide necessitates taking more appropriate
measures for mitigating virus spread and development of the effective theranostic agents. In …
measures for mitigating virus spread and development of the effective theranostic agents. In …